A study in The New England Journal of Medicine based on an analysis of blood samples of 1,240 people being treated for malaria in Southeast Asia and Africa revealed that detecting mutations in the kelch13 gene can quickly identify who has the resistant form of malaria. The study also found that artemisinin therapy can still eliminate even the most resistant form of malaria if a longer course of treatment is done.

Full Story:
New Scientist

Related Summaries